Experienced in Hypercalcemia

Dr. Daniel W. Coyne

Nephrology
Washington University
12654 Lamplighter Square Shpg Ctr, 
Saint Louis, MO 
Accepting New Patients
Offers Telehealth
Experienced in Hypercalcemia
Washington University
12654 Lamplighter Square Shpg Ctr, 
Saint Louis, MO 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Daniel Coyne is a Nephrologist in Saint Louis, Missouri. Dr. Coyne is rated as an Experienced provider by MediFind in the treatment of Hypercalcemia. His top areas of expertise are Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Nephrosclerosis, Renovascular Hypertension, and Parathyroidectomy. Dr. Coyne is currently accepting new patients.

His clinical research consists of co-authoring 55 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Hypercalcemia.

Specialties
Nephrology
Licenses
Internal Medicine in MO
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Cox Health
  • EPO
  • PPO
Essence Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Home State Health
  • EPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

WASHINGTON UNIVERSITY
12654 Lamplighter Square Shpg Ctr, Saint Louis, MO 63128
Other Locations
WASHINGTON UNIVERSITY
3740 S Jefferson Ave, Davita South City Dialysis, Saint Louis, MO 63118
WASHINGTON UNIVERSITY
2610 Clark Ave, Saint Louis, MO 63103
WASHINGTON UNIVERSITY
324 De Baliviere Ave, Saint Louis, MO 63112
WASHINGTON UNIVERSITY
11107 S Towne Sq, Saint Louis, MO 63123

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
Enrollment Status: Completed
Publish Date: April 02, 2024
Intervention Type: Drug
Study Drugs: Daprodustat, Darbepoetin Alpha
Study Phase: Phase 3
A Pilot Safety and Pharmacokinetic Study of MB-102 Versus Iohexol and the Use of the Non-invasive Optical Renal Function Monitor (ORFM) Device in Subjects With Normal and Impaired Renal Function and a Range of Skin Color Types
A Pilot Safety and Pharmacokinetic Study of MB-102 Versus Iohexol and the Use of the Non-invasive Optical Renal Function Monitor (ORFM) Device in Subjects With Normal and Impaired Renal Function and a Range of Skin Color Types
Enrollment Status: Completed
Publish Date: October 26, 2023
Intervention Type: Drug, Device
Study Drugs: MB-102, Iohexol
Study Phase: Phase 2
A 52-week Open-label (Sponsor-blind), Randomized, Active-controlled, Parallel-group, Multi-center Study to Evaluate the Efficacy and Safety of Daprodustat Compared to Recombinant Human Erythropoietin in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Initiating Dialysis
A 52-week Open-label (Sponsor-blind), Randomized, Active-controlled, Parallel-group, Multi-center Study to Evaluate the Efficacy and Safety of Daprodustat Compared to Recombinant Human Erythropoietin in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Initiating Dialysis
Enrollment Status: Completed
Publish Date: October 20, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trials

55 Total Publications

Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in Kidney Disease.
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in Kidney Disease.
Journal: NEJM evidence
Published: August 26, 2024
Similar Doctors
Advanced in Hypercalcemia
Dr. Gary G. Singer
Nephrology
Advanced in Hypercalcemia
Dr. Gary G. Singer
Nephrology

Midwest Nephrology Associates Inc

70 Jungermann Cir, Suite 302, 
Saint Peters, MO 
 (22.8 miles away)
636-720-0310
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Gary Singer is a Nephrologist in Saint Peters, Missouri. Dr. Singer is rated as a Distinguished provider by MediFind in the treatment of Hypercalcemia. His top areas of expertise are Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Acute Kidney Failure, Nephrosclerosis, and Kidney Transplant. Dr. Singer is currently accepting new patients.

Advanced in Hypercalcemia
Dr. Anahit S. Cheema
Nephrology
Advanced in Hypercalcemia
Dr. Anahit S. Cheema
Nephrology

Inderjit Singh MD Facp LLC

1400 Us Hwy 61, 
Festus, MO 
 (21.3 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Anahit Cheema is a Nephrologist in Festus, Missouri. Dr. Cheema is rated as a Distinguished provider by MediFind in the treatment of Hypercalcemia. His top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Kidney Disease, Acute Kidney Failure, Low Sodium Level, and Endoscopy. Dr. Cheema is currently accepting new patients.

Advanced in Hypercalcemia
Dr. Sarah K. Sundet
Nephrology
Advanced in Hypercalcemia
Dr. Sarah K. Sundet
Nephrology

St Louis Kidney Care LLC

1400 Us Hwy 61, Suite 240a, 
Festus, MO 
 (21.3 miles away)
636-937-3337
Languages Spoken:
English, Hindi, Sindhi, Urdu
See accepted insurances
Accepting New Patients

Sarah Sundet is a Nephrologist in Festus, Missouri. Dr. Sundet is rated as an Advanced provider by MediFind in the treatment of Hypercalcemia. Her top areas of expertise are Acute Kidney Failure, Chronic Kidney Disease, Nephrosclerosis, and Renovascular Hypertension. Dr. Sundet is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Coyne's expertise for a condition
ConditionClose
    View All 19 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile